A comparison of the efficacy of botulinum toxin type A induced protective ptosis and temporary tarsorrhaphy in persistent corneal epithelial defect conditions. (Pilot study)

Ratchadapiseksompotch Research Fund0 个研究点目标入组 11 人开始时间: 2013年6月27日最近更新: 2024年8月19日

适应症

试验速览

暂无简介。

•This research is a pilot study. The sample size is 15 cases for each controlled and intervention group. The small number of sample size is due to limited PED cases. A total of 30 consecutive patients (1 affected eye for each patient) will be recruited from general eye clinic at the department of ophthalmology, King Chulalongkorn Memorial Hospital. This trial will be conducted between October 2012 to October 2014, The inclusion criteria is as followings:
•Inclusion criteria :
•1.Age > 18 year
•2.Persistent corneal epithelial defect patient (1 affected eye for each patient)

•Exclusion criteria :
•1.Underlying disease that impairs corneal epithelial wound healing such as uncontrolled DM
•2.Contraindications to Botulinum toxin type A (BOTOX) or temporary tarsorrhaphy
•3.Uncontrolled corneal infection
•4.Complications from PED : perforation , progressive thinning , active infection , not heal in 3 months

发起方

Ratchadapiseksompotch Research Fund